Objective: To determine whether an fMRI memory encoding task distinguishes among cognitively normal elderly individuals, patients with mild cognitive impairment (MCI), and patients with early Alzheimer's disease (AD). Methods: Twenty-nine subjects (11 normal, 9 MCI, 9 AD) were studied with an fMRI memory encoding task. A passive sensory task was also performed to assess potential intergroup differences in fMRI responsiveness. Activation in the medial temporal lobe for the memory task and in the anatomic rolandic area for the sensory task was studied. Intergroup comparisons were performed using receiver operating characteristic (ROC) analyses. The ROC method provides rigorous control of artifactual false-positive "activation." Subjects were tested for recall and recognition of the encoding task stimuli following the fMRI study. Results: Medial temporal lobe activation was greater in subjects than MCI and AD patients (p ϭ 0.03 and p ϭ 0.04). There was no difference between AD and MCI patients in normal fMRI memory performance. There was an association between fMRI memory activation (area under the ROC curve) and post-fMRI performance on recognition and free recall. There was no difference among the three groups on the sensory task. Conclusions: MCI and AD patients had less medial temporal lobe activation on the memory task than the normal subjects but similar activation as normal subjects on the sensory task. These findings suggest decreased medial temporal activation may be a specific marker of limbic dysfunction due to the neurodegenerative changes of AD. In addition, fMRI is sufficiently sensitive to detect changes in the prodromal, MCI, phase of the disease.
Abstract-Objective:
To determine whether an fMRI memory encoding task distinguishes among cognitively normal elderly individuals, patients with mild cognitive impairment (MCI), and patients with early Alzheimer's disease (AD). Methods: Twenty-nine subjects (11 normal, 9 MCI, 9 AD) were studied with an fMRI memory encoding task. A passive sensory task was also performed to assess potential intergroup differences in fMRI responsiveness. Activation in the medial temporal lobe for the memory task and in the anatomic rolandic area for the sensory task was studied. Intergroup comparisons were performed using receiver operating characteristic (ROC) analyses. The ROC method provides rigorous control of artifactual false-positive "activation." Subjects were tested for recall and recognition of the encoding task stimuli following the fMRI study. Results: Medial temporal lobe activation was greater in subjects than MCI and AD patients (p ϭ 0.03 and p ϭ 0.04). There was no difference between AD and MCI patients in normal fMRI memory performance. There was an association between fMRI memory activation (area under the ROC curve) and post-fMRI performance on recognition and free recall. There was no difference among the three groups on the sensory task. Conclusions: MCI and AD patients had less medial temporal lobe activation on the memory task than the normal subjects but similar activation as normal subjects on the sensory task. These findings suggest decreased medial temporal activation may be a specific marker of limbic dysfunction due to the neurodegenerative changes of AD. In addition, fMRI is sufficiently sensitive to detect changes in the prodromal, MCI, phase of the disease. NEUROLOGY 2003; 61:500 -506 Several different fMRI activation paradigms show differences in activation between normal elderly and patients with Alzheimer's disease (AD), including visual saccades, 1 visual and motor responses, 2 semantic processing, 3, 4 angle discrimination, 5 and memory. [6] [7] [8] [9] Differences in fMRI activation are also found in individuals at risk for developing AD using attention, 10 naming, fluency, 11, 12 and memory 13 tasks.
Changes in memory function are of particular interest because memory impairment is a cardinal feature of AD and is the hallmark clinical feature of mild cognitive impairment-amnestic type (MCI). 14 Individuals with MCI are at significantly increased risk for eventually developing AD compared with cognitively normal elderly persons. 15 Early detection of alterations in brain function that underlie focal memory impairment has the potential to identify candidates for treatment that may halt or delay progression of cognitive deficits. FMRI holds promise as a potential noninvasive tool for detecting changes in brain function before individuals progress to meet clinical criteria for dementia and may complement other established imaging modalities. An often-heard axiom is that functional changes precede structural changes in neurodegenerative diseases. As a functional measure, fMRI therefore should theoretically have an advantage in early detection over other imaging techniques that detect disease-related structural changes.
The major aim of this study was to test the hypothesis that an fMRI memory encoding task discriminates among normal elderly, patients with MCI, and patients with early AD. A secondary hypothesis tested was that normal elderly, patients with MCI, and patients with early AD have similar activation in response to a passive sensory task. We tested these aims by comparing groups with receiver operating characteristic (ROC) analysis. We expected to find more robust medial temporal activation with the memory task in normal vs MCI or AD subjects and better activation in MCI than AD subjects. The sensory task was used as a control measure on which we expected to find no intergroup differences.
Methods. Subjects. All subjects were recruited from the Alzheimer's Disease Research Center (ADRC)/Alzheimer's Disease Patient Registry (ADPR) at the Mayo Clinic in Rochester, MN. These are institutional review board-approved prospective longitudinal databases of aging and dementia. 16 Informed consent was obtained from every subject (or their appropriate proxy) prior to participation. Thirty-five subjects were studied: 14 cognitively normal subjects, 11 patients with MCI, and 10 patients with early AD, although six of these studies were eventually discarded. All subjects completed neuropsychological testing as part of the standard procedure for participation in the ADRC/ADPR. Prior to recruitment for this fMRI study, participants had been assigned to diagnostic group categories during ADRC/ADPR Consensus Committee meetings consisting of a geriatrician, neurologists, neuropsychologists, psychometrists, and nurses who had seen the patient.
Criteria for the diagnosis of cognitively normal control subjects were 1) no active neurologic or psychiatric disorders; 2) if medical problems were present, the illnesses or their treatments did not interfere with cognitive function; 3) a normal neurologic exam; 4) no psychoactive medication; and 5) independently functioning community dwellers.
The clinical criteria for the diagnosis of MCI were 1) memory complaint, preferably corroborated by an informant; 2) objective memory impairment for age and education 17, 18 ; 3) largely normal general cognitive function; 4) essentially intact activities of daily living; 5) not demented. 19 The diagnostic determination reflected clinical judgment and was not based on fixed cutoff scores on psychometric tests.
The diagnosis of probable AD was made according to the Diagnostic and Statistical Manual for Mental Disorders, 3rd ed. rev., criteria for dementia and National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria for AD. 19, 20 All AD patients recruited for this study had a Clinical Dementia Rating (CDR) 21 score of 0.5 or 1.0 and Mini-Mental State Examination 22 (MMSE) score of Ն20. This step was taken to ensure that AD patients were cognitively capable of performing the fMRI memory activation paradigm.
Recruitment exclusionary criteria. Potential subjects were excluded if they demonstrated evidence for cortical infarction, excessive subcortical vascular disease, space-occupying lesions, non-AD dementing disorders, or concurrent illnesses other than AD that might interfere with cognitive function. Standard MRI exclusionary criteria, e.g., pacemaker, were incorporated as well.
Memory activation paradigm. All subjects completed training prior to the scanning session that included an overview of the memory and sensory tasks. Subjects were fitted with MRcompatible lenses if needed.
The memory activation paradigm was designed to emphasize encoding and consisted of four full cycles. Each cycle consisted of a half-cycle of the activation task for 21 seconds and a half-cycle of the foil task for 21 seconds. Prior to the scan, subjects were reminded to carefully memorize each picture for later recall and recognition testing. During each activation half-cycle, 3 photographs were presented at a rate of 1 every 7 seconds, for a total of 12 photographs viewed during the entire scanning run. The photographs consisted of scenes of people engaged in activities of daily living and were drawn from a library that was compiled for this purpose (Photodisc, Seattle, WA, 1994). The foil portion of the paradigm consisted of the presentation of a single pixelated image in which the pixels of one of the photographs were randomly reshuffled and the original image was not recognizable. The pixilated image controlled for basic aspects of visual processing such as luminance and color level proportion but did not control for specific aspects of feature detection and object recognition. We used a nonrecognizable stimulus for the foil rather than a control photograph to simplify the task and avoid confusion in the impaired subjects.
Visual stimuli were presented via a visual liquid crystal display mounted on a birdcage head coil. The stimulus presentation was synched with the scanner to provide precise temporal coordination between the MR scanning parameters and stimulus delivery.
Subjects were tested for free recall of the pictures immediately after the encoding run while still in the MR scanner. They were tested for recognition memory in a forced choice format outside the scanner approximately 5 minutes after the study was completed.
Sensory activation paradigm. To assess for potential systematic differences in the ability to mount an fMRI blood oxygenation level-dependent (BOLD) response across the three clinical groups, a sensory fMRI activation task was also performed on each volunteer during the same scanning session as the memory task. We employed a passive palm-brushing task. This activation paradigm also consisted of four full cycles. Each cycle was divided into a 21-second half-cycle of rest alternated with a 21-second half-cycle of right-hand stimulation. To ensure experimental uniformities, the palm brushing was performed by the same individual (MMM) on all subjects.
Image acquisition. Whole-brain asymmetric spin echo echoplanar imaging (EPI) fMRI (repetition time [TR] 2,750 milliseconds, echo time [TE] 50 milliseconds, echo offset of Ϫ20 msec, field of view [FOV] 24 cm, matrix 64 ϫ 64) was performed using a 3.0 T scanner (General Electric, Milwaukee, WI). Twenty-six contiguous 5-mm axial slices were selected to provide coverage of the entire brain. Each functional run consisted of 64 time course image volumes. The duration of the scan was limited so that the total exam time was tolerable for elderly subjects. Each set of multislice images was preceded by orbital navigator echoes in the sagittal, axial, and coronal planes to record subject motion during the scan. 23 In addition, real-time calculation of activation maps allowed visual inspection of results such that scans with obvious motion artifact could be discarded. Motion parameters from all 3°o f rotational freedom and 3 mm of translational freedom obtained from the orbital navigator data were examined after each study. We discarded studies that had Ͼ3 mm of translation or Ͼ3°of rotation. This resulted in a final data set of 11 normal subjects (3 discarded), 9 MCI (2 discarded) and 9 AD (1 discarded). Each subject also underwent a three-dimensional spoiled gradient-recalled (SPGR) anatomic reference scan (TR 17 milliseconds, TE 5 milliseconds, FOV ϭ 24 cm, matrix ϭ 512 ϫ 192, 1.5-mm-thick coronal images) during the same scanning session as the functional runs.
Data analysis. The time series data were initially processed in AFNI. 24 Correlation coefficients for the memory and sensory tasks were calculated using a staggered sinusoidal stimulus waveform function. The correlation coefficient was calculated between signal intensity cycling in MRI and the known timing of the activation paradigm on a pixel-by-pixel basis. A representative functional map of the memory task is shown in figure 1 . Retrospective motion correction of the EPI volumes within each fMRI time series was completed with the 3dReg AFNI plug-in. Next, the EPI volumes and high-resolution anatomic SPGR images were spatially registered for each run using ANALYZE. 25 A potential weakness in fMRI data analysis is the practice of selecting pixels with correlation coefficients that exceed a single arbitrarily determined threshold to represent "true" activation. 26 An alternative approach, used here, is ROC curve analysis. In ROC analysis, the relationship of true and false activation levels is probed without imposing a threshold to make a binary decision on whether or not a voxel is activated. Instead, a range of thresholds is considered. To perform ROC analyses, we defined neuroanatomic regions of interest (ROIs) in which activation should appear with a specific task and then accumulated probability tables for voxels in the region. The pertinent ROI for the memory task was the medial temporal lobe and for the sensory task the anatomic pre-and postcentral gyri. ROIs were drawn on the highresolution T1-weighted images of every subject, which had been spatially registered to that subject's fMRI EPI image volume.
The ROI for the memory task encompassed the hippocampi, parahippocampal gyri, and fusiform gyri bilaterally. This ROI included the entire hippocampus along its anteroposterior extent. 27 The posterior border of the medial temporal lobe ROI was determined by the slice on which the hippocampal fornix was visible in full profile. The anterior boundary was determined by the most anterior slice on which the head of the hippocampus was visualized. The lateral border was the occipitotemporal sulcus. The medial border of the ROI was the CSF-brain interface in the uncal cistern. The superior border was the hippocampal-CSF interface in the choroid fissure. Figure 2 shows the ROI for the memory encoding task.
The ROI for the sensory task was the hand region of the sensorimotor homunculus. This can be determined unequivocally using reliable neuroanatomic landmarks on axial T1-weighted images to identify the pre-and postcentral gyri and the central sulcus. [28] [29] [30] [31] [32] [33] [34] [35] [36] The sensory ROIs were drawn on axial slices for each participant. Figure 3 shows the ROI for the sensory task.
For a given fMRI time series, a series of activation maps were generated by incrementally varying the correlation coefficient threshold from 0 to 1.0. At any given correlation coefficient threshold, the true-positive fraction (TPF) was defined as the number of pixels in the ROI (i.e., medial temporal lobe for memory task, sensorimotor strip for sensory task) that exceeded the threshold divided by the total number of pixels in the ROI. The false-positive fraction (FPF) was defined as an estimate of the distribution under the null hypothesis divided by the total number of pixels in the same ROI. The false-positive activation estimates were obtained by permuting the temporal ordering of the time series data. 37 For each voxel, 2,000 random permutations of the time series data were generated. For each permutation of the time series data, a correlation coefficient was calculated. These pseudo-correlation coefficients for the permuted data were tabulated as false-positive activation estimates within each ROI. Thus, true-positive correlation coefficient distributions in each ROI were compared with an estimate of the pseudo-correlation coefficient distribution under the null hypothesis (i.e., the FPF) in the same ROI: medial temporal for the memory task and perirolandic for the sensory paradigm. Traditional ROC curves were then generated with sensitivity (TPF) on the ordinate and 1 Ϫ specificity (FPF) on the abscissa 26, 38, 39 and plotted across an FPF range of 0 to 0.05.
Statistics. Nonparametric values were used for descriptive purposes and hypothesis testing. To test for an effect of clinical group membership on fMRI activation (i.e., area under the ROC curve), Spearman rank correlations were performed on the combined fMRI data for all three groups, treating group as an ordinal variable. A series of one-sided rank sum pairwise comparisons were performed to test for differences in fMRI performance (area under the ROC curve across an FPF range of 0 to 0.05) between pairs of subject groups. These analyses were performed separately for the memory and sensory fMRI tasks. A Spearman rank correlation was also performed to test for an association between the area under the ROC curve vs performance on the free recall task among all 29 subjects combined.
Results. There were no differences between the groups in age, education, gender, and handedness. As expected, the groups were different on the MMSE, 22 Mattis Dementia Rating Scale, 40 percent retention on the Rey Auditory Verbal Learning Test, 41 and CDR Sum of Box scores 21 (see  table 1 ). Table 2 lists the median and interquartile range for the area under the ROC curve for each patient group for the memory and sensory tasks. A group membership effect was present on memory task activation performance (r ϭ Ϫ0.37, p ϭ 0.02) but not on the sensory task. For the memory task, pairwise rank sum tests indicated a difference between the normal subjects and MCI patients (p ϭ 0.03) and between the normal subjects and AD pa- tients (p ϭ 0.04) but not between the MCI and AD patients (p ϭ 0.5). Group ROC curves for the memory encoding task are shown in figure 4. For a given fMRI time series, as the correlation coefficient threshold is moved successively from low to high values, there is corresponding movement from the upper right-to the lower left-hand portion of the ROC curve. Activation performance of the normal subjects was better (ROC curve to the left of) than that of the MCI and AD groups. The MCI and AD groups were not significantly different. On a descriptive basis, seven of the AD patients' individual ROC curves were to the right of (below) the normal subjects' median. Conversely, nine of the normal subjects' individual ROC curves were to the left (above) and two were to the right (below) of the AD patients' median. Of the nine AD patients, six were taking Aricept (Eisai Co., Tokyo, Japan) when they completed this study. There was no association between use of Aricept and area under the ROC curve in the AD group.
As expected, there were also group differences on free recall performance immediately after the scanning run and on recognition performance completed outside the scanner (table 3) . The AD group consistently performed the most poorly, but their performance on the recognition test indicates that on average they were attending to the stimuli while in the scanner. There was an association between performance on the fMRI memory task (area under the ROC curve) and performance on post-fMRI free recall (r ϭ 0.39, p ϭ 0.05) across all 29 subjects. Values are medians (interquartile range), expressed as area ϫ 10 Ϫ3 . Since the true-positive fraction and 1 Ϫ false-positive fraction are proportions, they are unitless, and the area under the curve is also unitless. Pairwise comparisons were completed between each clinical group for both tasks. There was a significant difference between the normal and MCI subjects (rank sum test, one-sided, p ϭ 0.03) and normal and AD subjects (rank sum test, one-sided, p ϭ 0.04) for the memory task but not between the MCI and AD subjects. The difference between the groups on the sensory task was not significant. visual scene encoding paradigm. We found that activation in this brain region is greater in normal subjects than in patients with MCI and AD. The MCI patients were not significantly different from AD patients. Our interpretation of these data is that the AD-related neurodegenerative changes in the medial temporal lobe produce a functional (fMRI) impairment in MCI patients that is of roughly equivalent magnitude to that observed in AD subjects. One measure of the potential sensitivity of any diagnostic test to early changes of AD is its ability to discriminate patients in the prodromal (MCI) phase from cognitively normal control subjects. Our results are encouraging in that regard. However, a more rigorous test of early diagnostic sensitivity is the ability of a test to predict whether or not individual elderly subjects will or will not eventually progress to AD. Our results do not address this issue at this time, but this is planned in the future. We employed a passive sensory task as a control experiment to confirm that members of each clinical group on average had the potential to produce an equivalent BOLD response. There was no significant difference between the groups on the passive sensory task, which we interpret to mean that the MCI and AD groups' depressed memory fMRI activation is not simply due to a globally impaired BOLD response. The results also imply that the depressed fMRI activation seen on the memory task in AD and MCI patients is not a nonspecific disease-related phenomenon; rather, it is specific for a functional domain (memory) that clinically differs profoundly between cognitively normal and impaired subjects. When the memory and sensory results are considered together, they suggest that decreased temporal lobe activation may be a specific marker of medial temporal lobe dysfunction due to neurodegenerative disease, not a nonspecific marker of old age.
Discussion. Medial temporal lobe activation can be obtained in the elderly with an fMRI complex
Other groups have also assessed memory with fMRI in AD. Reduced fMRI activation has been reported in the hippocampal and entorhinal areas with memory tasks. [6] [7] [8] [9] Although we are not aware of any fMRI study that has specifically evaluated MCI subjects, our results agree in general with the aforementioned publications. Compensatory increased activation has been found in AD subjects during an encoding task in the medial parietal, posterior cingulate, and superior frontal regions. 9 Using the ROC method, we were not in a position to evaluate all possible brain areas and therefore cannot compare our results with studies in which extratemporal activation was evaluated.
Others have measured subregions of the medial temporal lobe (subiculum, entorhinal cortex) and found differences in memory activation among subgroups of individuals with memory decline relative to normal subjects. 8 The spatial resolution of the raw EPI images in our fMRI acquisition (3.75 ϫ 3.75 ϫ 5 mm) was coarser than the structures in question; the width of the entorhinal cortex or subiculum is in the range of 3 to 4 mm. We therefore elected not to attempt to isolate fMRI activation to specific sub-fields of the hippocampal formation (e.g., subiculum or CA1) or the entorhinal cortex.
There is no universally agreed upon method for analyzing fMRI data. The ROC method has advantages and disadvantages, and we do not mean to imply that it is necessarily the preferred method of fMRI analysis in all circumstances. An advantage is that it provides a systematic way to control for artifactual false-positive "activation" in the image data across subjects. A disadvantage is that one must make a priori assumptions about where activation will occur. Unlike widely used brain-mapping methods, the ROC method does not allow one to compare potential intergroup activation differences across the entire three-dimensional volume of the brain. Despite this limitation, however, the ROC method may be quite useful for certain diagnostic questions, and it may also allow straightforward comparison of results between investigators. We employed well established functional-anatomic relationships for ROI definition in this study: medial temporal lobe for memory function and paracentral sulcus for primary sensory function. We felt that for this particular study, the improved reliability resulting from strict accounting of false-positive artifactual activation was worth the associated trade-off of loss of anatomic coverage.
Another advantage of the ROC technique is the use of ROIs that are drawn on an individual's anatomy. Precise spatial registration among subjects is necessary if one is using the brain-mapping approach to fMRI analysis, i.e., testing for intergroup differences in image space after spatial normalization. With the ROC approach, one does not need to rely on precise spatial registration among subjects because the ROIs are drawn uniquely to each subject's anatomy.
The particular implementation of the ROC method we used entailed calculating the true-and false-positive activation fraction in the same area of the brain for a given task. This has at least two useful properties. First, the number of pixels used to calculate the true-positive and false-positive fractions is identical. Second, different areas of the brain have their own unique noise properties. By using the same ROI for the true-and false-positive calculation, the noise properties are, in theory, better matched than if different areas of the brain were used to calculate the TPF vs FPF.
We acknowledge that there are inherent inaccuracies in tracing anatomic boundaries on near-isotropic T1-wighted images and then superimposing these traces on spatially registered fMRI time series image data that were acquired as 5-mm-thick axial slices. This is particularly true in the medial temporal lobe where susceptibility artifacts commonly cause anatomic distortion. Although we used a spin-echo echo planar acquisition specifically to minimize this phenomenon, some degree of distortion in susceptible areas is an inherent feature of most fMRI acquisition sequences. We drew the ROIs as "loose traces" around the medial temporal structures to account for the possibility of anatomic mismatch between the SPGR and the time series data. As a result, we did not exclude areas of medial temporal activation from the ROI, but we did include some CSF in the medial temporal ROI. Including CSF in the ROI decreased sensitivity by including inert-i.e., nonactivating pixels-in the calculation of the TPF.
We limited the FPF range of the ROC curves from 0 to 0.05. While this choice may be arbitrary, had we extended the FPF range to Ͼ0.05, we would have, by definition, been accepting Ͼ5% false-positive pixels as true-positive activation. Limiting the FPF range to Ͻ0.05 may be equivalent to the standard statistical practice of limiting the a priori probability of type I error to Ͻ5%.
We did not directly assess responses during the memory activation paradigm and therefore cannot guarantee that all subjects were fully attending to stimuli. We opted not to use a handheld response unit owing to the difficulty subjects had in using the device as well as to reduce the probability of head motion during scans. Nonetheless, free recall on postscan testing corresponded to neurocognitive data and area under the ROC curve; and performance on the recognition test suggests that subjects were complying with directions.
Another limitation of this study, and fMRI in general, is the dropout rate due to motion corruption. Despite limiting the duration of each run as well as the entire scan time, we had to exclude 17% of our subjects because of excessive motion artifact. Advances in prospective motion correction engineering technology could substantially improve the reliability of fMRI for clinical purposes.
Our results indicate that the fMRI BOLD response of individuals with MCI during a memory paradigm is comparable to individuals with AD. Contrary to our expectation, the MCI and AD groups were indistinguishable in our data. Different activation paradigms and evaluation of activation in other brain regions with the objective of distinguishing MCI from AD may be a fruitful area for future studies. The results we have obtained, while somewhat preliminary and focused only on medial temporal lobe activation, are nonetheless encouraging as they imply that fMRI is sufficiently sensitive to detect AD-related changes in the prodromal, MCI, phase of the disease. 32 4 peripheral and central sensitization, 5, 6 and impaired sympathetic function. [7] [8] [9] Despite these known pathophysiologic components of CRPS, a pathophysiologic explanation for the entire disease remains unknown. 6 Based on clinical findings, such as tremor, dystonia, or hemisensory impairment, additional widespread involvement of the CNS has been suggested. 3, [10] [11] [12] Transcranial magnetic stimulation (TMS) is a useful noninvasive technique to assess the excitability of the motor system. Using paired-pulse TMS with a subthreshold conditioning and a suprathreshold test stimulus, the response to the test stimulus is inhibited at short and facilitated at longer interstimulus intervals (ISIs) in healthy humans. [13] [14] [15] [16] These phenomena are referred to as intracortical inhibition (ICI) and intracortical facilitation (ICF) because they are thought to reflect the activity of inhibitory and facilitatory interneuronal circuits in the motor cortex. 13, 15, 17 In contrast, motor threshold (MT) assessed by single-pulse TMS is thought to reflect the excitability of the most excitable parts of the motor system in general. 18 Abnormalities of ICI and ICF or MT were found in patients with several neurologic disorders involving the central motor system, [19] [20] [21] but also after peripheral deafferentation. 22, 23 In the present study, we used TMS to assess changes of motor excitability and their possible relationship to clinical symptoms in patients with CRPS I to obtain further insight into the underlying pathophysiologic mechanisms.
Methods. Subjects. We studied 25 patients (16 women, 9 men) who fulfilled the clinical criteria of CRPS I 1 at diagnosis. These criteria were 1) symptoms developed after an initiating noxious event; 2) spontaneous pain or allodynia and hyperalgesia occurred and were not limited to the territory of a single peripheral nerve and were disproportionate to the inciting event; 3) there was or had been evidence of edema, skin blood flow abnormality, or abnormal sudomotor activity in the region of the pain since the inciting event; and 4) the diagnosis was excluded by the existence of conditions that would otherwise account for the degree of pain and dysfunction. Only patients with a unilateral affection of the upper limbs were selected. Patients with peripheral nerve lesions or other neurologic disorders were excluded. The patients' ages ranged between 29 and 80 years (median, 50 years), and the period since diagnosis ranged between 0.5 and 231.0 months (median, 10.0 months). The patients did not take central acting drugs when participating in the study. A standard neurologic examination was performed in each patient. To evaluate impairment of sensation, the entire body surface was tested for light-touch perception using cotton wool. In the painful area, particular attention was given to mechanical allodynia elicited by light pressure. Pinprick sensation was tested clinically using the sharp and blunt side of a wooden stick. Thermal testing was performed using test tubes filled with warm (38°C) or cold (22°C) water. With respect to the spatial extension of sensory deficits, patients were subdivided into patients with hemisensory impairment and patients with sensory impairment limited to the affected limb. The presence of tremor or dystonia was noted. Immediately before starting the TMS session, each patient filled out a 10-cm visual analogue scale (VAS), in which the scale varied between 0 and 10, to assess the actual pain intensity and the mean and maximum ongoing pain intensity during the previous week. Additionally, each patient was asked to estimate the remaining use of the affected hand (expressed as a percentage of the use before trauma). The clinical features of the patients are reported in the table. Results obtained from the patients were compared with results recorded from a control group of 20 right-handed healthy volunteers (10 women, 10 men; aged 20 to 78 years; median, 49 years). All subjects participating in the study gave their informed consent. The local ethical committee approved the study.
Transcranial magnetic stimulation. TMS was performed using a Bistim module, which was connected to two Magstim 200 stimulators (Magstim Co., Whitland, Dyfed, UK). The stimuli were applied through a circular coil (outer diameter, 14 cm) positioned over the vertex with the current flowing counterclockwise in the coil to activate predominantly the left hemisphere, and clockwise to activate predominantly the right hemisphere. While stimulating the contralateral hemisphere, recordings were taken with Ag-AgCl surface electrodes from the first dorsal interosseus (FDI) muscle consecutively on both sides in the patients and only from the right FDI in the control group. They were stored on an EMG machine (Neuropack 8, Nihon Kohden, Tokyo, Japan) for further analysis. The signals were amplified with a bandpass of 20 Hz to 3 kHz, sweep duration of 10 to 50 ms/division, and gain of 0.1 to 1 mV/division. MT was determined at rest to the nearest 1% of the stimulator output and was defined as the minimum intensity that produced 5 motor evoked potentials (MEPs) Ͼ50 V out of 10 trials. The corticocortical excitability (ICI and ICF) was tested in the resting muscle using a paired-pulse paradigm. 13 The second stimulus (test stimulus) was adjusted to evoke an MEP of approximately 1.0 mV; the conditioning stimulus was set at 80% of the individual MT. The ISIs of 1, 2, 3, 4, 8, 10, 15, and 20 ms were chosen. For each interval, at least eight responses were collected. The paired pulses were mixed with 32 suprathreshold single control stimuli using the same stimulation intensity as for the second (test) stimulus. For each ISI, the amplitude ratio of the mean conditioned MEP to the control MEP was calculated. For all recordings, subjects were given audiovisual feedback at high gain to assist complete muscle relaxation. If EMG activity became ap- CRPS ϭ complex regional pain syndrome; W ϭ women; M ϭ men; l ϭ left; r ϭ right; VAS ϭ visual analogue scaling. parent during data collection, including a 10-ms prestimulus interval, responses were rejected. Statistical analysis. For the paired-pulse TMS, the inhibitory ISIs (1 to 4 ms) were analyzed separately from the facilitatory ISIs (8 to 20 ms). The results obtained from the patients' affected side were compared with the patients' clinically unaffected side using Student's paired t-tests. For these paired t-tests, the significance level was adjusted by dividing it by the number of comparisons (0.05 Ϭ 4 ϭ 0.0125, Bonferroni correction for multiple comparisons). The results from the patients' affected and clinically unaffected sides were compared separately with the results of the control group using an analysis of variance (ANOVA) for repeated measurements (within-subject factor "ISI," between-subject factor "group") with an adjusted significance level of 0.05 Ϭ 2 ϭ 0.025.
To detect a possible relationship between clinical features and ICI or ICF, an ANOVA for repeated measurements was calculated, with hemisensory impairment, allodynia, and tremor as between-subject factors, and age, duration since diagnosis, pain intensity, and use of the affected hand as covariates. For the MT, Student's paired t-test was used to compare the affected and the clinically unaffected side, and Student's unpaired t-test was used to compare patients and control subjects and clinical subgroups. Significance was assumed at the 0.05 level. For all statistical tests, the SPSS 11.0.1 software package (SPSS software, Munich, Germany) was used.
Results. Intracortical inhibition. Regarding the inhibitory 1-to 4-ms ISI (figure, A), no significant difference was found between the patients' affected and clinically unaffected side at one of the ISIs. Comparing results of the patients' affected side with the control group, ANOVA revealed a significant influence of the factor "ISI" (i.e., 1, 2, 3, or 4 ms) and a significant influence of the factor "group" (i.e., control group or patients' affected side) with a reduced inhibition on the patients' affected side (mean amplitude ratio, 49.8 Ϯ 34.0% SD) compared with healthy control subjects (31.1 Ϯ 22.0%, p ϭ 0.006). There was no significant interaction between both factors. Comparing the results of patients' unaffected side with the control group, there was also a significant influence of the factor "ISI" and the factor "group," with a reduced inhibition on the patients' unaffected side (48.5 Ϯ 33.6%) compared with control subjects (p ϭ 0.012). Again, there was no significant interaction between both factors.
Regarding the clinical features, the mean and the maximal pain intensity during the previous week were linked to a reduced ICI on the affected side but not on the clinically unaffected side (ANOVA, covariate effect on the affected side F ϭ 6.354, p ϭ 0.040 for the mean and F ϭ 7.359, p ϭ 0.030 for the maximal pain intensity). Other clinical features (hemisensory impairment, allodynia, tremor, age, duration since diagnosis, use of the affected hand) did not influence ICI on either the affected or clinically unaffected side.
Intracortical facilitation. Regarding the facilitatory 8to 20-ms ISI (figure, B) , there was also no significant difference between the patients' affected and clinically unaffected side at one of the ISIs. Comparing the patients' affected side and unaffected side with the control group, there was neither a significant effect of the factor "ISI" (i.e., 8, 10, 15, or 20 ms) nor of the factor "group" (i.e., control group and patients' affected or unaffected side), and there was no significant interaction between these two factors. Mean amplitude ratio was 136.7 Ϯ 96.0% SD on the patients' affected side, 141.1 Ϯ 69.8% on the patients' clinically unaffected side, and 136.0 Ϯ 37.2% for the control group. ICF was not influenced by one of the clinical features on either the affected or the clinically unaffected side.
Motor threshold. MT did not differ significantly between the patients' clinically unaffected side (52.1 Ϯ 10.0% of maximum stimulator output) and the patients' affected side (51.6 Ϯ 9.2%). There was also no significant difference between the control group (48.7 Ϯ 9.2%) and either the patients' affected or unaffected side. MT on the affected side was lower in patients with allodynia (45.0 Ϯ 4.1%) than in those without allodynia (55.4 Ϯ 8.2%, p ϭ 0.005), whereas it did not differ between these two subgroups on the clinically unaffected side (49.0 Ϯ 5.7% in patients with allodynia vs 54.2 Ϯ 10.8% in patients without allodynia, p ϭ 0.240).
MEP amplitudes after single control stimuli. MEP amplitudes after single control stimuli did not differ significantly between the patients' clinically unaffected side (1.07 Ϯ 0.61 mV), the patients' affected side (1.00 Ϯ 0.54 mV), and the control group (1.12 Ϯ 0.44 mV).
Discussion. The main finding in patients with CRPS I was a reduced ICI in both the hemisphere contralateral to the affected and contralateral to the clinically unaffected hand. The phenomenon of ICI as assessed by TMS is the result of strong ␥-aminobutyric acid (GABA)-dependent inhibitory and weaker NMDA-dependent excitatory interneuronal circuits in the motor cortex. [24] [25] [26] [27] Therefore our results suggest a bilateral reduction of GABA-related motor cortical inhibition or an enhancement of NMDA-dependent excitatory mechanisms, or both.
In patients with limb amputation, a similar disinhibition was observed exclusively in the hemisphere contralateral to the amputation, which is discussed with respect to the altered peripheral input. 22, 23 An alteration of the peripheral input to the primary somatosensory and primary motor cortex, which are both closely linked via cortical horizontal connections, 28 may also contribute to the observed disinhibition in the hemisphere contralateral to CRPS I. This disinhibition was particularly pronounced in patients with higher pain intensity. Because this finding was the result of an exploratory data analysis, further studies are required to firmly establish this relationship. However, it suggests that chronic pain in patients with CRPS induces central changes of sensorimotor processing, which may also result in clinical abnormalities such as hemisensory impairment in a subgroup of CRPS patients. 11, 29 However, the disinhibition in the hemisphere contralateral to the clinically unaffected side is more difficult to explain. The finding of a bilateral motor cortex disinhibition in patients with CRPS is supported by the results of a MEG study, which showed a bilaterally altered reactivity of the 20-Hz motor cortex rhythm, with a significantly shorter and smaller 20-Hz rebound after tactile stimuli in patients with CRPS. 30 Because the rebound of the 20-Hz rhythm is thought to reflect increased motor cortex inhibition, 31 these findings also suggest a bilaterally modified inhibition of the motor cortex. Interestingly, in clinical reports CRPS was found not only to spread from the affected hand to the ipsilateral unaffected foot but also to the contralateral hand, or to show an initial bilateral distribution. [32] [33] [34] [35] [36] [37] [38] [39] There is evidence that unilateral nerve lesions may produce transsynaptic changes in the contralateral spinal cord dorsal horn, [40] [41] [42] and a simultaneous appearance of bilateral pain hypersensitivity after unilateral nerve injury has been described in animal models of peripheral neuropathy. 43, 44 These effects are likely mediated by a central mechanism involving the system of commissural interneurons in the spinal cord and brainstem. 45 It can be speculated that similar mechanisms could occur after subclinical traumatic nerve lesions in patients with CRPS I and therefore be related to the bilateral spread of CRPS in previous studies and to the bilateral motor cortex disinhibition seen in our study. Alternatively, the bilateral disinhibition could indicate a preexistent increased susceptibility to CRPS.
Using the same TMS paradigm, a reduced ICI was found in patients with focal task-specific dystonia not only in the contralateral hemisphere but also in the ipsilateral hemisphere. 19 This was attributed to a bilaterally disturbed motor cortex input from the basal ganglia. Further evidence for this hypothesis came from a recent fMRI study, showing an increased basal ganglia output via the thalamus to the motor and premotor cortical areas in patients with focal dystonia. 46 Because dystonia is not an unusual clinical phenomenon in patients with CRPS I, 3 and it may even show a multifocal or generalized distribution pattern in a subgroup of patients, 12 our results could also be explained by a bilateral involvement of the basal ganglia during the course of the disease. However, this basal ganglia involvement might often be subclinical because dystonia was rarely observed in our patients. Interestingly, the amount of disinhibition in the hemisphere ipsilateral to CRPS I was not associated with pain intensity or duration since diagnosis. This leads to the assumption that the bilateral cortical disinhibition is not just a secondary phenomenon resulting from pain. It suggests a generalized involvement of the central motor system, which occurs early during the course of the disease and remains present years after its initiation.
Unlike changes in ICI, an alteration of ICF or MT was not a common phenomenon in patients with CRPS I when compared with healthy subjects. However, when analyzing clinical subgroups, MT was significantly lower in patients with allodynia than in patients without allodynia on the affected, but not on the clinically unaffected, side. A decrease in MT may be the result of increased excitability of the first (central) or second (spinal) motoneuron because MT reflects the excitability of the most excitable parts of the motor system in general. 18 Therefore evoked pain as present in allodynia may exert a differential influence on motor excitability at different (spinal or cortical) levels on both sides. As for the relationship between pain and ICI, these findings have to be firmly established in further studies.
Considering the clinical relevance of our findings, the bilateral motor cortex disinhibition may not be a specific neurophysiologic marker for CRPS I because there is considerable overlap between patients and control subjects and because a reduced ICI has been reported not only in patients with dystonia and after amputation but also in patients with a wide range of other neurologic and psychiatric disorders, such as Parkinson's disease, 20 Alzheimer's disease, 47 Tourette's syndrome, 48 and schizophrenia. 49 However, our findings give additional evidence for CNS involvement during the course of the disease and therefore encourage further research to develop therapeutical strategies that are able to target this CNS involvement in patients with CRPS I.
